A detailed history of Prestige Wealth Management Group LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 961 shares of EW stock, worth $65,117. This represents 0.01% of its overall portfolio holdings.

Number of Shares
961
Previous 869 10.59%
Holding current value
$65,117
Previous $80,000 21.25%
% of portfolio
0.01%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $5,492 - $8,627
92 Added 10.59%
961 $63,000
Q4 2023

Apr 26, 2024

SELL
$61.71 - $77.76 $308 - $388
-5 Reduced 0.57%
869 $66,000
Q4 2023

Feb 08, 2024

SELL
$61.71 - $77.76 $308 - $388
-5 Reduced 0.57%
869 $66,000
Q3 2023

Apr 26, 2024

BUY
$69.28 - $93.38 $277 - $373
4 Added 0.46%
874 $60,000
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $277 - $373
4 Added 0.46%
874 $60,000
Q1 2023

Apr 26, 2024

BUY
$74.26 - $84.51 $74 - $84
1 Added 0.12%
870 $71,000
Q1 2023

May 16, 2023

SELL
$74.26 - $84.51 $1,410 - $1,605
-19 Reduced 2.14%
870 $71,000
Q4 2022

Feb 07, 2023

SELL
$68.3 - $87.44 $79,637 - $101,955
-1,166 Reduced 56.74%
889 $66,000
Q3 2022

Nov 01, 2022

BUY
$82.37 - $107.29 $9,225 - $12,016
112 Added 5.76%
2,055 $170,000
Q2 2022

Aug 10, 2022

BUY
$86.5 - $128.27 $96,361 - $142,892
1,114 Added 134.38%
1,943 $184,000
Q1 2022

May 05, 2022

BUY
$101.96 - $128.34 $20,392 - $25,668
200 Added 31.8%
829 $98,000
Q4 2021

Feb 15, 2022

BUY
$106.37 - $130.68 $8,509 - $10,454
80 Added 14.57%
629 $81,000
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $10,291 - $12,275
-100 Reduced 15.41%
549 $63,000
Q4 2020

Feb 17, 2021

BUY
$71.69 - $91.23 $286 - $364
4 Added 0.62%
649 $59,000
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $24,339 - $32,549
423 Added 190.54%
645 $44,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $14,622 - $22,599
-279 Reduced 55.69%
222 $42,000
Q4 2019

Jan 28, 2020

BUY
$71.7 - $82.09 $2,509 - $2,873
35 Added 7.51%
501 $117,000
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $7,078 - $8,674
115 Added 32.76%
466 $102,000
Q2 2019

Aug 16, 2019

BUY
$55.74 - $64.41 $13,990 - $16,166
251 Added 251.0%
351 $65,000
Q1 2019

Aug 16, 2019

BUY
$47.89 - $64.05 $3,256 - $4,355
68 Added 212.5%
100 $19,000
Q4 2018

Apr 16, 2019

BUY
$46.41 - $56.94 $1,485 - $1,822
32 New
32 $5,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.